LFMD · LifeMD, Inc.
$2.72
-0.02 (-0.73%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$143.16M
Shares
48.20M
Volume · Oct 5
802.51K
Avg daily vol (3M)
846.54K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.72
Open$2.86
Day$2.67–2.86
52W close$2.64–6.94
Avg vol 30d775K
Short int7.4M · 15.3% float · 7.5d
Short vol57%
Last earningsAug 5, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 5
Up next
Next earnings call
Nov 11, 2026
Est · unconfirmed
· in 5 wks
filed Aug 5, 2026
call held May 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$191.59M
Trailing 12 months
Net income (TTM)
−$330,834
Trailing 12 months
Revenue growth YoY
-3.5%
Year over year
Operating margin
-10.5%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-7.7%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+7.6%
Year over year · more shares
Price change (1Y)
-61.0%
Trailing year
Short interest
15.3%
Latest settlement · 7.5 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 15.5 · calm
Equity put/call 0.59
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−28%
below
Price vs 50-day avg
−17%
below
RSI (14)
33
neutral
MACD trend
Negative
52-week position
2%
near low
Momentum
relative strength
1-month return
−12%
trailing
6-month return
−28%
trailing
YTD return
−20%
this year
Relative strength
−39%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
1 of 117 funds reported for Sep 30 · net +337 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
15.34% of float · ▲ +2.2% MoM · 7.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
117 holders — mid 3-yr range
Squeeze score
65
elevated · 0–100
Fundamentals
Revenue growth
+50%
Y/Y
Gross margin
1334%
contracting
EPS growth
+142%
Y/Y
Free cash flow
$6.4M
Quant / Vol
risk profile
Volatility
80%
annualized · 1-yr
Max drawdown
−62%
past year
ATR
6.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 5, 2026
third quarter of 2026
Revenue
Initiated
$48M – $51M
prior qtr $47.28M
midpoint +4.7% QoQ
full year 2026
Revenue
Initiated
$205.5M – $212.5M
prior FY $194.06M
midpoint +7.7% Y/Y
fourth quarter 2026
Revenue
Initiated
$60M – $64M
prior qtr $47.28M
midpoint +31.1% QoQ
Adjusted EBITDA
Non-GAAP
Initiated
$3M – $6M
Guided vs delivered
· last 2 settled
Full year 2021 revenue
full year 2021
guided $90M – $100M
$92.88M
In line
Full-year 2020 revenue
full-year 2020
guided at least $40M
$37.29M
Miss −6.8%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−28%
Bearish
Price vs 50-day avg
−17%
Bearish
RSI (14)
33
Neutral
MACD trend
Negative
Bearish
52-week position
2%
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $3 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
1 of 117 funds reported for Sep 30 · net +337 sh shares
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
15.34% of float · ▲ +2.2% MoM · 7.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
117 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $3
Now $3 · 2%
Range high $7
vs 200-day avg -28%
vs 50-day avg -17%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -$7,988,110 | Six Months Ended June 30, 2026 | — |
| Weight Management Program subscribers | 108,000 | Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LFMD
this stock
LifeMD, Inc.
|
$143.16M | -20.2% | +49.8% | — | 15.3% |
|
VEEV
Veeva Systems Inc
|
$45.44B | +27.0% | +28.1% | 45.9 | 3.1% |
|
TEM
Tempus AI, Inc.
|
$15.34B | +41.5% | +83.4% | — | 15.6% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$12.20B | -29.7% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$11.02B | +65.6% | +28.2% | 33.8 | 5.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LFMD | -7.2% | -11.7% | -27.9% | -6.2% | -20.2% |
| SPY | +1.2% | +0.6% | +11.6% | +1.6% | +13.6% |
| vs SPY | -8.4% | -12.3% | -39.4% | -7.8% | -33.9% |